Chronic β2-adrenergic receptor stimulation increases proliferation of human cardiac fibroblasts via an autocrine mechanism

Cardiovascular Research

Volumn 57, Issue 3, 2003, Pages 784-792

  Turner, Neil A ^a   Porter, Karen E ^a   Smith, William H T ^a   White, Hazel L ^a   Ball, Stephen G ^a   Balmforth, Anthony J ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Adrenergic (ant)agonists; Cell culture isolation; Growth factors; Heart failure; Remodeling

Indexed keywords

ADENYLATE CYCLASE; ALPRENOLOL; ATENOLOL; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CATECHOLAMINE DERIVATIVE; CYCLIC AMP; FORSKOLIN; GROWTH FACTOR; ISOPRENALINE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P42; PROTEIN P44; 3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PROPANOLAMINE DERIVATIVE;

ARTICLE; AUTOCRINE EFFECT; BIOPSY; CELL COUNT; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; FETAL CALF SERUM; FIBROBLAST; HEART RIGHT ATRIUM; HEAT TREATMENT; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STIMULATION; CELL CULTURE; CELL DIVISION; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; HEART ATRIUM; HEART MUSCLE; METABOLISM; PHYSIOLOGY;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; AUTOCRINE COMMUNICATION; CELL DIVISION; CELLS, CULTURED; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; HEART ATRIA; HUMANS; ISOPROTERENOL; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCARDIUM; PROPANOLAMINES; RECEPTORS, ADRENERGIC, BETA-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0037370388     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(02)00729-0     Document Type: Article

References (34)

1. Swedberg K., Viquerat C., Rouleau J.L., et al. Comparison of myocardial catecholamine balance in chronic congestive heart failure and in angina pectoris without heart failure. Am J Cardiol. 54:1984;783-786.
2. Hasking G.J., Esler M.D., Jennings G.L., Burton D., Johns J.A., Korner P.I. Norepinephrine spillover to plasma in patients with chronic congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation. 73:1986;615-621.
3. Bristow M.R. β-Adrenergic receptor blockade in chronic heart failure. Circulation. 101:2000;558-569.
4. Villarreal F.J., Kim N.N. Regulation of myocardial extracellular matrix components by mechanical and chemical growth factors. Cardiovasc Pathol. 7:1998;145-151.
5. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev. 79:1999;215-262.
6. Scheuer J. Catecholamines in cardiac hypertrophy. Am J Cardiol. 83:1999;70H-74H.
7. Singh K., Communal C., Sawyer D.B., Colucci W.S. Adrenergic regulation of myocardial apoptosis. Cardiovasc Res. 45:2000;713-719.
8. Wintersgill H.P., Warburton P., Bryson S.E., Ball S.G., Balmforth A.J. Characterization of the angiotensin II receptor expressed by the human hepatoma cell line, PLC-PRF-5. Eur J Pharmacol Mol Pharmacol. 227:1992;283-291.
9. 1A receptor internalisation. Cell Signal. 13:2001;269-277.
10. 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. Pharmacol Rev. 43:1991;203-242.
11. 2-adrenoceptors in single myocytes from human ventricle. Circulation. 88:1993;854-863.
12. 2-adrenoceptor in human ventricular myocytes. J Mol Cell Cardiol. 32:2000;1353-1360.
13. Long C.S., Hartogensis W.E., Simpson P.C. β-Adrenergic stimulation of cardiac non-myocytes augments the growth-promoting activity of non-myocyte conditioned medium. J Mol Cell Cardiol. 25:1993;915-925.
14. s. Am J Physiol Cell Physiol. 278:2000;C154-C162.
15. Gustafsson A.B., Brunton L.L. β-Adrenergic stimulation of rat cardiac fibroblasts enhances induction of nitric-oxide synthase by interleukin-1β via message stabilization. Mol Pharmacol. 58:2000;1470-1478.
16. Bhambi B., Eghbali M. Effect of norepinephrine on myocardial collagen gene expression and response of cardiac fibroblasts after norepinephrine treatment. Am J Pathol. 139:1991;1131-1142.
17. Calderone A., Thaik C.M., Takahashi N., Chang D.L., Colucci W.S. Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts. J Clin Invest. 101:1998;812-818.
18. Zheng J.-S., O'Neill L., Long X., et al. Stimulation of P2Y receptors activates c-fos gene expression and inhibits DNA synthesis in cultured cardiac fibroblasts. Cardiovasc Res. 37:1998;718-728.
19. Leicht M., Greipel N., Zimmer H.-G. Comitogenic effect of catecholamines on rat cardiac fibroblasts in culture. Cardiovasc Res. 48:2000;274-284.
20. Tsuruda T., Kato J., Kitamura K., et al. An autocrine or a paracrine role of adrenomedullin in modulating cardiac fibroblast growth. Cardiovasc Res. 43:1999;958-967.
21. Marienfeld U., Walter U., Simm A. Inhibition of rat cardiac fibroblast growth by cAMP - but not by cGMP-dependent protein kinase. Basic Res Cardiol. 96:2001;184-191.
22. Dubey R.K., Gillespie D.G., Mi Z., Jackson E.K. Endogenous cyclic AMP-adenosine pathway regulates cardiac fibroblast growth. Hypertension. 37:2001;1095-1100.
23. Colombo F., Noël J., Mayers P., Mercier I., Calderone A. β-Adrenergic stimulation of rat cardiac fibroblasts promotes protein synthesis via the activation of phosphatidylinositol 3-kinase. J Mol Cell Cardiol. 33:2001;1091-1106.
24. Kim J., Eckhart A.D., Eguchi S., Koch W.J. β-Adrenergic receptor-mediated DNA synthesis in cardiac fibroblasts is dependent on transactivation of the epidermal growth factor receptor and subsequent activation of extracellular signal-regulated kinases. J Biol Chem. 35:2002;32116-32123.
25. Hafizi S., Chester A.H., Yacoub M.H. Inhibition of human cardiac fibroblast mitogenesis by blockade of mitogen-activated protein kinase and phosphatidylinositol 3-kinase. Clin Exp Pharm Physiol. 26:1999;511-513.
26. Katwa L.C., Campbell S.E., Tyagi S.C., Lee S.J., Cicila G.T., Weber K.T. Cultured myofibroblasts generate angiotensin peptides de novo. J Mol Cell Cardiol. 29:1997;1375-1386.
27. Yokoyama T., Sekiguchi K., Tanaka T., et al. Angiotensin II and mechanical stretch induce production of tumor necrosis factor in cardiac fibroblasts. Am J Physiol. 276:1999;H1968-H1976.
28. 1 and endothelin-1 from fibroblasts. Cardiovasc Res. 40:1998;352-363.
29. Zhao L., Eghbali-Webb M. Release of pro- and anti-angiogenic factors by human cardiac fibroblasts: effects on DNA synthesis and protection under hypoxia in human endothelial cells. Biochim Biophys Acta. 1538:2001;273-282.
30. Fisher S.A., Absher M. Norepinephrine and ANG II stimulate secretion of TGF-β by neonatal rat cardiac fibroblasts in vitro. Am J Physiol. 268:1995;C910-C917.
31. Dostal D.E., Booz G.W., Baker K.M. Regulation of angiotensinogen gene expression and protein in neonatal rat cardiac fibroblasts by glucocorticoid and β-adrenergic stimulation. Basic Res Cardiol. 95:2000;485-490.
32. Satoh C., Fukuda N., Hu W.Y., Nakayama M., Kishioka H., Kanmatsuse K. Role of endogenous angiotensin II in the increased expression of growth factors in vascular smooth muscle cells from spontaneously hypertensive rats. J Cardiovasc Pharmacol. 37:2001;108-118.
33. Witte K., Thackray S., Clark A.L., Cooklin M., Cleland J.G. Clinical trials update: IMPROVEMENT-HF, COPERNICUS, MUSTIC, ASPECT-II, APRICOT and HEART. Eur J Heart Fail. 2:2000;455-460.
34. Bristow M.R. What type of β-blocker should be used to treat chronic heart failure? Circulation. 102:2000;484-486.